Patents/Inventors

Henryk T. Dudek

Belmont, MAUS13 patents

13 Patents

US125347302026
Compositions and Methods for Inhibiting GYS2 Expression
NOVO NORDISK A/S
0 cites
US124353362025
Compositions and Methods for Inhibiting LPA Expression
Dicerna Pharmaceuticals, Inc.
0 cites
US122526912025
Compositions and Methods for Inhibiting LPA Expression
Dicerna Pharmaceuticals, Inc.
0 cites
US120846622024
Compositions and Methods for Modulating PNPLA3 Expression
Dicerna Pharmaceuticals, Inc.
0 cites
US119129962024
Methods and Compositions for the Specific Inhibition of Alpha-1 Antitrypsin by Double-stranded RNA
DICERNA PHARMACEUTICALS, Inc.
0 cites
US118734932024
Methods and Compositions for the Specific Inhibition of Glycolate Oxidase (HAO1) by Double-stranded RNA
Dicerna Pharmaceuticals, Inc.
0 cites
US118516582023
Methods and Compositions for the Specific Inhibition of Alpha-1 Antitrypsin by Double-stranded RNA
Dicerna Pharmaceuticals, Inc.
0 cites
US117733902023
Methods and Compositions for the Specific Inhibition of Complement Component 5(C5) by Double-stranded RNA
Dicerna Pharmaceuticals, Inc.
0 cites
US116978122023
Methods and Compositions for the Specific Inhibition of Transthyretin (TTR) by Double-stranded RNA
Dicerna Pharmaceuticals, Inc.
0 cites
US116679182023
Methods and Compositions for the Specific Inhibition of Antithrombin 3 (AT3) by Double-stranded RNA
Dicerna Pharmaceuticals, Inc.
0 cites
US116616042023
Methods and Compositions for Inhibiting Expression of LDHA
DICERNA PHARMACEUTICALS, Inc.
0 cites
US115725622023
Compositions and Methods for Inhibiting GYS2 Expression
Dicerna Pharmaceuticals, Inc.
0 cites
US115662482023
PCSK9 Targeting Oligonucleotides for Treating Hypercholesterolemia and Related Conditions
Dicerna Pharmaceuticals, Inc.
0 cites